Ethyleneoxynitazene
Synthetic opioid analgesic
| Ethyleneoxynitazene | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Ethyleneoxynitazene is a potent synthetic opioid analgesic that belongs to the nitrobenzimidazole class of compounds. It is structurally related to etodesnitazene and is known for its high potency and potential for abuse.
Chemical Structure and Properties
Ethyleneoxynitazene is characterized by its complex chemical structure, which includes a nitrobenzimidazole core. This structure is responsible for its high affinity for the mu-opioid receptor, which is the primary target for opioid analgesics. The chemical formula of ethyleneoxynitazene is C22H26N4O3, and it has a molecular weight of 394.47 g/mol.
Pharmacology
Ethyleneoxynitazene acts as a full agonist at the mu-opioid receptor, similar to other opioids such as morphine and fentanyl. This receptor interaction is responsible for its analgesic effects, as well as its potential for causing respiratory depression, a common risk associated with opioid use. The potency of ethyleneoxynitazene is significantly higher than that of morphine, making it a substance of concern in terms of overdose risk.
Medical Use
Currently, ethyleneoxynitazene is not approved for medical use in humans. Its high potency and risk of abuse have limited its application in clinical settings. Research into its potential therapeutic uses is ongoing, but it remains primarily a subject of interest in the context of opioid research and drug development.
Legal Status
Due to its high potency and potential for abuse, ethyleneoxynitazene is classified as a controlled substance in many jurisdictions. It is often included in the same regulatory categories as other potent synthetic opioids, which are subject to strict controls to prevent misuse and illegal distribution.
Safety and Toxicity
The safety profile of ethyleneoxynitazene is not well-established, but it is known to carry similar risks to other opioids, including the potential for addiction, overdose, and death. The risk of respiratory depression is particularly high, especially when used in combination with other central nervous system depressants such as alcohol or benzodiazepines.
Related Compounds
Ethyleneoxynitazene is part of a broader class of nitrobenzimidazole opioids, which includes compounds such as isotonitazene and metonitazene. These compounds share similar structural features and pharmacological profiles, contributing to their classification as potent synthetic opioids.
Related Pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD